Back

E3 ubiquitin ligase targets nucleolin and modulates its phase separation to suppress ribosome biogenesis in myocardial infarction hearts

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Ageing, senescence, and epigenetic regulation Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Yangxin Li

First Affiliated Hospital of Soochow University, Suzhou (China)

5 More presentations in this session

Presentation thumbnail
Pharmacological modulation of cardiac senescence reveals divergent transcriptomic reversal patterns in human cardiomyocytes
Doctor K. Megnis (Riga, LV)
Abstract Slides Video
Presentation thumbnail
AI-driven prediction and experimental validation of nucleolin phase separation during aging
Professor Y. Li (Suzhou, CN)
Abstract Slides Video
Presentation thumbnail
Targeting PERK-driven proteostasis signalling reveals spermidine-dependent stress resilience in the ageing heart
Ms N. Kanduri (SE)
Abstract Slides Video
Presentation thumbnail
Oxidative dysregulation as central mechanisms of PANDA lncRNA in diabetic vasculature
Ms A. Mongelli (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Succinate induces histone succinylation to accelerate arterial calcification by activating FRA1/CREB3L2 axis
Doctor Z. Guan (Shenzhen, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Ageing, senescence, and epigenetic regulation

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
METTL3 drives heart failure by regulating Spp1 and Fos m6A modification in myocardial infarction
2 September 2024
thumbnail
Congress Presentation
Microtubule-induced restriction of nuclear deformability in hypertrophic cardiomyopathy
13 April 2024
thumbnail
Congress Presentation
Impaired autophagy mechanisms associated with phospholamban-R14del disease
12 April 2024
thumbnail
Congress Presentation
Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after doxorubicin treatment
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources